Mostrando 2 resultados de: 2
Subtipo de publicación
Article(2)
Origen
scopus(2)
Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof-of-Principle Issues from a Randomized Controlled Study
ArticleAbstract: Background: Several pieces of evidence have shown the neurotrophic effect of erythropoietin (EPO) anPalabras claves:Clinical trial, erythropoietin, human-recombinant erythropoietin, spinocerebellar ataxia type 2Autores:Almaguer Gotay D., Amaro-González D., Aymed-García J., Batista-Nuñez M., Canales-Ochoa N., Carmen Elena Viada, Columbié Ximelis J., Crombet-Ramos T., Estupiñán Rodriguez A., García-García I., García-Rodriguez J.C., Hernández Casaña P., Jiménez-Rodríguez D., Labrada Aguilera P.E., Medrano Montero J., Ortega-Sanchez R., Padrón-Estupiñan M.d.C., Peña Acosta A., Rodríguez-Labrada R., Rodriguez-Obaya T., Santos-Morales O., Silva Ricardo Y., Torres Vega R., Tribin Rivero K., Valenzuela-Silva C.M., Valle Cabrera R., Vazquez-Mojena Y., Velazquez-Perez L.Fuentes:scopusEvaluation of quality of life in patients with non-small cell lung cancer treated with CIMAvaxEGF® vaccine
ArticleAbstract: This report corresponds to quality of life analysis of patient with non-small cell lung cancer incluPalabras claves:Cancer Vaccines, clinical trials, Non-small cell lung cancer, quality of life, surveys and questionnairesAutores:Álvarez-Cardona M., Carmen Elena Viada, Crombet-Ramos T., Frías-Blanco A., Lorenzo-Monteagudo G., Neninger-Vinagera E., Ramos-Suzarte M., Rodríguez P.C.Fuentes:scopus